Marathon Oil (MRO) has recently been on Zacks.com’s list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock’s performance in the near future.
Over the past month, shares of this energy company have returned -34.3%, compared to the Zacks S&P 500 composite’s -6.6% change. During this period, the Zacks Oil and Gas – Integrated – United States industry, which Marathon Oil falls in, has lost 24.6%. The key question now is: What could be the stock’s future direction?
While media releases or rumors about a substantial change in a company’s business prospects usually make its stock ‘trending’ and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate Revisions
Rather than focusing on anything else, we at Zacks prioritize evaluating the change in a company’s earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors’ interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in estimate earnings revisions and near-term stock price movements.
Marathon Oil is expected to post earnings of $1.30 per share for the current quarter, representing a year-over-year change of +490.9%. Over the last 30 days, the Zacks Consensus Estimate has changed +1.1%.
The consensus earnings estimate of $5.16 for the current fiscal year indicates a year-over-year change of +228.7%. This estimate has changed +0.8% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $4.58 indicates a change of -11.2% from what Marathon Oil is expected to report a year ago. Over the past month, the estimate has changed +1.3%.
With an impressive externally audited track record, our proprietary stock rating tool — the Zacks Rank — is a more conclusive indicator of a stock’s near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Marathon Oil.
The chart below shows the evolution of the company’s forward 12-month consensus EPS estimate:
Revenue Growth Forecast
Even though a company’s earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It’s almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company’s potential revenue growth is crucial.
In the case of Marathon Oil, the consensus sales estimate of $2.05 billion for the current quarter points to a year-over-year change of +79.5%. The $8.08 billion and $7.52 billion estimates for the current and next fiscal years indicate changes of +47.7% and -6.9%, respectively.
Last Reported Results and Surprise History
Marathon Oil reported revenues of $1.75 billion in the last reported quarter, representing a year-over-year change of +63.7%. EPS of $1.02 for the same period compares with $0.21 a year ago.
Compared to the Zacks Consensus Estimate of $1.81 billion, the reported revenues represent a surprise of -3.06%. The EPS surprise was +4.08%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates two times over this period.
No investment decision can be efficient without considering a stock’s valuation. Whether a stock’s current price rightly reflects the intrinsic value of the underlying business and the company’s growth prospects is an essential determinant of its future price performance.
Comparing the current value of a company’s valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on ), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Marathon Oil is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
The facts discussed here and much other information on Zacks.com might help determine whether or not it’s worthwhile paying attention to the market buzz about Marathon Oil. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Click to get this free report
Marathon Oil Corporation (MRO): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.